Volume 8, Issue 1 (Winter 2019)                   JOHE 2019, 8(1): 12-20 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Khosravani Poor H, Ali Akbar Poor M, Zare Askari A, Danesh M, Keshavarz A, Palizian B. Lifetime prevalence of cutaneous leishmaniasis scar in the city of Kherameh, Fars province, Iran (2015). JOHE. 2019; 8 (1) :12-20
URL: http://johe.rums.ac.ir/article-1-329-en.html
1- Islamic Azad Semnan University, Semnan, Iran. , dehkadehjahani00a@gmail. com
2- Shiraz University of Medical Science, Shiraz, Iran.
3- Islamic Azad Semnan University, Semnan, Iran
4- Shiraz University, Shiraz, Iran.
Abstract:   (1195 Views)
Background: Second only to malaria, cutaneous leishmaniasis is considered the most serious disease in tropical and subtropical areas around the world. Although leishmaniasis is a self-limited disease, the scar left by it on the affected person’s skin can cause mental and emotional problems. The present study investigated the lifetime prevalence of cutaneous leishmaniasis scar among the affected people in the city of Kherameh in 2015.
Materials and Methods: Using a census method in this cross-sectional study, we interviewed 11905 families in the city of Kherameh. The epidemiological data were collected using a researcher-made questionnaire prepared through scientific methods and were analyzed through Pearson, t-test, Fisher's, and Chi-square tests.
Results: The cutaneous leishmaniasis prevalence was estimated to be 31.49% across the studied area, with the scar lifetime prevalence of 25.93% and 20.32% among the female and male participants, respectively. The highest age-gender specific prevalence was found among the 5-9 years old female participants. Furthermore, the risk of the disease recurrence was found to be 0.68%.
Conclusion: There was a high rate of the cutaneous leishmaniasis prevalence in the region under study and it was found that the disease do not provide lifelong immunity. To control the disease, it is necessary to find more effective solutions and take appropriate controlling actions.

Full-Text [PDF 432 kb]   (254 Downloads) |   |   Full-Text (HTML)  (158 Views)  
Type of Study: original article | Subject: Epidemiology
Received: 2018/10/23 | Accepted: 2019/02/17 | ePublished: 2019/04/29

1. Vazirianzadeh B, Hoseini SA, Pour Rezaee S, Gardani H, Amraee K. Prevalence of cutaneous leishmaniasis in Ramshir, Iran; an epidemiological study. Quarterly of International Archives of Health Sciences 2014;1(1):37-41. [Article]
2. Miura R, Kooriyama T, Yoneda M, Takenaka A, Doki M, Goto Y, et al. Efficacy of recombinant canine distemper virus expressing leishmania antigen against leishmania challenge in dogs. PLoS Negl Trop Dis 2015; 9(7):e0003914. [DO] [PMID] [PMCID]
3. Maroli M, Feliciangeli MD, Bichaud L, Charrel RN, Gradoni L. Phlebotomine sandflies and the spreading of leishmaniases and other diseases of public health concern. . Med Vet Entomol 2013; 27(2):123-47. [DOI] [PMID]
4. Savoia D. Recent updates and perspectives on leishmaniasis. J Infect Dev Ctries 2015; 9(6):588-96. [DOI] [PMID]
5. Achtman JC, Ellis DL, Saylors B, Boh EE. Cutaneous leishmaniasis caused by Leishmania (Viannia) panamensis in 2 travelers. JAAD Case Rep 2016; 2(2):95-7. [DOI] [PMID] [PMCID]
6. Entezari M, Eskandari F. Relationship between climatic factors and the prevalence of cutaneous leishmaniasis in Larestan city. Journal of Military Medicine 2014; 16(2):99-104. [Article]
7. Olalla HR, Velez LN, Kato H, Hashiguchi K, Caceres AG, Gomez EA, et al. An analysis of reported cases of leishmaniasis in the southern Ecuadorian Amazon region, 1986-2012. Acta Trop 2015; 146:119-26. [DOI] [PMID]
8. Oré M, Sáenz E, Cabrera R, Sanchez JF, De Los Santos MB, Lucas CM, et al. Outbreak of cutaneous leishmaniasis in Peruvian military personnel undertaking training activities in the Amazon basin, 2010. Am J Trop Med Hyg 2015; 93(2):340-6. [DOI] [PMID] [PMCID]
9. Mondragon-Shem K, Acosta-Serrano A. Cutaneous leishmaniasis: The truth about the ‘Flesh-Eating Disease’ in Syria. Trends Parasitol 2016; 32(6):432-5. [DOI] [PMID]
10. Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One 2012; 7(5):e35671. [DOI] [PMID] [PMCID]
11. Khosravani M, Nasiri Z, Keshavarz D, Rafat-Panah A. Epidemiological trend of cutaneous leishmaniasis in two endemic focus of disease, south of Iran. J Parasit Dis 2016; 40(4):1609-13. [DOI] [PMID] [PMCID]
12. Ono M, Takahashi K, Taira K, Uezato H, Takamura S, Izaki S. Cutaneous leishmaniasis in a Japanese returnee from West Africa successfully treated with liposomal amphotericin B. J Dermatol 2011; 38(11):1062-5. [DOI] [PMID]
13. Haouas N. Estimations of cutaneous leishmaniasis burden: a constant challenge. Lancet Infect Dis 2016; 16(5):515-6. [DOI] [PubMed]
14. Mesgarian F, Rahbarian N, Mahmoudi Rad M, Hajaran H, Shahbaz F, Mesgarian Z, et al. Identification of leishmania species isolated from human cutaneous leishmaniasis in Gonbad-e-Qabus city using a PCR method during 2006-2007. Tehran University Medical Journal 2010; 68(4):250-6. [Article]
15. Bennis I, De Brouwere V, Ameur B, El Idrissi Laamrani A, Chichaoui S, Hamid S, et al. Control of cutaneous leishmaniasis caused by Leishmania major in south-eastern Morocco. Trop Med Int Health 2015; 20(10):1297-305. [DOI] [PMID]
16. Saatchi M, Salehiniya H, Khazaei S, Mohammadian M, Mohammadian-Hafshejani A. Cutaneous leishmaniasis in Iran: Demographic description and therapeutic outcomes. Journal of Dermatology and Cosmetic 2015; 6(2):108-18. [Article]
17. Jaffary F, Nilforoushzadeh MA, Abdellahi L, Mortazaei S. Cutaneous leishmaniasis reinfection: Skin Disease and Leishmaniasis Research Center, Isfahan, Iran. Journal of Isfahan Medical School 2015; 33(341):1029-36.
18. Mitropoulos P, Konidas P, Durkin-Konidas M. New World cutaneous leishmaniasis: updated review of current and future diagnosis and treatment. J Am Acad Dermatol 2010; 63(2):309-22. [DOI] [PMID]
19. Nejad Nayrisi H, Alhani F, Anoosheh M, Faghihzadeh S. The effect of designed home visit program on promoting cutaneous leishmaniasis preventive behaviors. Iran Journal of Nursing 2007; 20(49):73-100.
20. Zahirnia A, Moradi A, Norozi NA, Bathaii SJN, Erfani H, Moradi A. Epidemiology survey of cutaneous leishmaniasis in Hamadan province (2002-2007). Avicenna Journal of Clinical Medicine 2009; 16(1):43-7. [Article]
21. Sarkari B, Qasem A, Shafaf MR. Knowledge, attitude, and practices related to cutaneous leishmaniasis in an endemic focus of cutaneous leishmaniasis, Southern Iran. Asian Pac J Trop Biomed 2014; 4(7):566-9. [DOI] [PMID] [PMCID]
22. Yazdanpanah H, Baratiyan A, Karimi S. Investigation of the relationship of the climatic factors and prevalence of cutaneous in Ghasr Shirin City. Journal of Spatial Planning 2013; 3(3):69-86.
23. Jarahi L, Tayarani Bathaee A, Erfanian MR. A study on the effect of physical environment conditions on the prevalence of cutaneous leishmaniasis in leishmania hyperendemic area in Mashhad. Journal of Research in Environmental Health 2015; 1(3):228-33. [Article]
24. Saberi S, Zamani A, Moatamedi N, Nilforoushzadeh MA, Jaffary F, Rahimi E, et al. The knowledge, attitude and prevention practices of students regarding cutaneous leishmaniasis in the hyperendemic region of the Shahid Babaie Airbase. Vector Borne Zoonotic Dis 2012; 12(4):306-9. [DOI] [PMID]
25. Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S. Cutaneous leishmaniasis. Lancet Infect Dis 2007; 7(9):581-96. [DOI] [PMID]
26. Khazaei S, Mohammadian Hafshejani A, Saatchi M, Salehiniya H, Nematollahi Sh. Epidemiological aspects of cutaneous leishmaniasis in Iran. Arch Clin Infect Dis 2015; 10(3):e28511. [Article] [DOI]
27. Inci R, Ozturk P, Mulayim MK, Ozturk K, Alatas ET, Inci MF. Effect of the syrian civil war on prevalence of cutaneous leishmaniasis in southeastern Anatolia, Turkey. Med Sci Monit 2015; 21:2100-4. [DOI] [PMID] [PMCID]
28. Khan I, Hussain M, Ul Akbar N, Ahmad H, Ahmad W, Waqar M, et al. Prevalence of cutaneous leishmaniasis in Surgul village of district Kohat, Khayber Pakhtunkhwa. International Journal of Advancements in Research & Technology 2013; 2(12):141-7. [Article]
29. Eilami O, Khalili RS. Frequency of cutaneous leishmaniasis among patients referred to the Center for Disease Control in Kuhgilooyeh and Boyerahmad province 2009-2013. International Journal of Infectious Diseases 2016; 45(Supplement 1):222. [Article] [DOI]
30. Aflatotounian MR, Sharifi I. Prevalence rete of cutaneous leishmaniasis in Bam district during 20 years (1988-2007). Journal of Kerman University of Medical Sciences 2010; 17(4):297-306. [Article]
31. Nejati J, Mojadam M, Hanafi Bojd AA, Keyhani A, Habibi Nodeh F. An epidemiological study of cutaneous leishmaniasis in Andimeshk (2005-2010). Journal of Ilam University of Medical Sciences 2014; 21(7):94-101. [Article]
32. Alvar J, Yactayo S, Bern C. Leishmaniasis and poverty. Trends Parasitol 2006; 22(12):552-7. [DOI] [PMID]
33. Poorsmaelian S, Mirzaei M, Sharifi I, Zarean M. The prevalence of cutaneous leishmaniasis in the city and suburb of Mohammadabad, Jiroft district and identification of parasite species by Nested-PCR, 2008. Journal of Kerman University of Medical Sciences 2011; 18(3):218-27. [Article]
34. Nilforoushzadeh MA, Shirani-Bidabadi L, Hosseini SM, Fadaei-Nobari R, Jaffary F. The epidemiology of cutaneous leishmaniasis in Isfahan province, Iran, during 2001-2011. Journal of Isfahan Medical School 2015; 32(315):2241-51.
35. Reithinger R, Mohsen M, Leslie T. Risk factors for anthroponotic cutaneous Leishmaniasis at the household level in Kabul, Afghanistan. PLoS Negl Trop Dis 2010; 4(3):e639. [DOI] [PMID] [PMCID]
36. Soares L, Abad-Franch F, Ferraz G. Epidemiology of cutaneous leishmaniasis in central Amazonia: a comparison of sex-biased incidence among rural settlers and field biologists. Trop Med Int Health 2014; 19(8):988-95. [DOI] [PMID]
37. Yoon-Soo B, Boer-Kimball A, Alora-Palli M. Gender differences in perceptions of aging. J Am Acad Dermatol 2009; 60(3):AB24. [DOI] [PMID]
38. Sparavigna A, Setaro M, Di Pietro A. Heathy skin 2005": results of an Italian study on healthy population with particular regard to the aging phenomenon. Journal of Plastic Dermatology 2006; 2:23-9.
39. Khajedaluee M, Yazdanpanah MJ, Seyed Nozadi SM, Fata A, Juya MR, Masoudi MH, et al. Epidemiology of cutaneous leishmaniasis in Razavi Khorasan in 2011. Medical Journal of Mashhad University of Medical Sciences 2014; 57(4):647-54. [Article]
40. Doroodgar A, Mahbobi S, Nemetian M, Sayyah M, Doroodgar M. An epidemiological study of cutaneous leishmaniasis in Kashan (2007-2008). Journal of Semnan University of Medical Sciences 2009; 10(3):177-84.
41. Saberi S, Hejazi SH, Jafari R, Bahadoran M, Akbari M, Soleymanifard S, et al. The cutaneous leishmaniasis reservoirs in northern Baraan region of Isfahan, Iran. Journal of Isfahan Medical School 2013; 31(253):1497-507.
42. Babaei GhR, Shayan A. An epidemiological study of cutaneous leishmaniasis and the investigation of scar with emphesis on seasons, age and sex group in paalam, south of Lorestan province. Armaghane danesh Journal 2003; 8(29):51-8.
43. Abazid N, Jones C, Davies CR. Knowledge, attitudes and practices about leishmaniasis among cutaneous leishmaniasis patients in Aleppo, Syrian Arab Republic. East Mediterr Health J 2012; 18(1):7-14. [DOI] [PMID]
44. Heshmati H, Charkazi A, Hazavehei SMM, Rahaei Z, Dehnadi A. Factors related to cutaneous leishmaniasis preventive behaviors on the basis of BASNEF Model in residents of endemic areas in Yazd, Iran. Journal of Researches in Health System 2011; 7(6):926-34.
45. Vahabi A, Rassi Y, Oshaghi MA, Vahabi B, Rafizadeh S, Sayyad S. First survey on knowledge, attitude and practice about cutaneous leishmaniasis among dwellers of Musian district, Dehloran county, southwestern of Iran. Life Sci J 2013; 10(12 SPL.ISS):864-8. [Article]
46. Ali A, Ur Rehman T, Akhtar Qureshi A, Ur Rahman H. New endemic focus of cutaneous leishmaniasis in Pakistan and future epidemics threats. Asian Pac J Trop Dis 2016; 6(2):155-9. [DOI]
47. Faraj C, Yukich J, Adlaoui EB, Wahabi R, Mnzava AP, Kaddaf M, et al. Effectiveness and cost of insecticide-treated bed nets and indoor residual spraying for the control of cutaneous leishmaniasis: A cluster-randomized control trial in Morocco. Am J Trop Med Hyg 2016; 94(3):679-85. [DOI] [PMID] [PMCID]
48. Jalouk L, Al Ahmed M, Gradoni L, Maroli M. Insecticide-treated bednets to prevent anthroponotic cutaneous leishmaniasis in Aleppo Governorate, Syria: results from two trials. Trans R Soc Trop Med Hyg 2007; 101(4):360-7. [DOI] [PMID]
49. Neuber H. Leishmaniasis. J Dtsch Dermatol Ges 2008; 6(9):754-65. [DOI] [PMID]
50. Mohaghegh A. survey of epidemiological parametric of cutaneous leishmaniasis, determination of dominant species and nocturnal activity of sand flies in sultanabad area of shiraz as a new foci during 2004-2005. [PhD thesis]. Shiraz: Shiraz University of Medical Sciences; 2005.

Add your comments about this article : Your username or Email:

Send email to the article author

© 2020 All Rights Reserved | Journal of Occupational Health and Epidemiology

Designed & Developed by : Yektaweb